ES2082390T3 - Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias. - Google Patents

Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias.

Info

Publication number
ES2082390T3
ES2082390T3 ES92310807T ES92310807T ES2082390T3 ES 2082390 T3 ES2082390 T3 ES 2082390T3 ES 92310807 T ES92310807 T ES 92310807T ES 92310807 T ES92310807 T ES 92310807T ES 2082390 T3 ES2082390 T3 ES 2082390T3
Authority
ES
Spain
Prior art keywords
gamma
linolenic acid
reoclusion
preparation
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92310807T
Other languages
English (en)
Spanish (es)
Inventor
David Frederick Horrobin
John Charles Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Application granted granted Critical
Publication of ES2082390T3 publication Critical patent/ES2082390T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Control Of Turbines (AREA)
  • Glass Compositions (AREA)
  • Amplifiers (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Drying Of Semiconductors (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Semiconductor Lasers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES92310807T 1991-12-02 1992-11-26 Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias. Expired - Lifetime ES2082390T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125602A GB9125602D0 (en) 1991-12-02 1991-12-02 Method of preventing reocclusion of arteries

Publications (1)

Publication Number Publication Date
ES2082390T3 true ES2082390T3 (es) 1996-03-16

Family

ID=10705559

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92310807T Expired - Lifetime ES2082390T3 (es) 1991-12-02 1992-11-26 Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias.

Country Status (17)

Country Link
US (2) US5378732A (enExample)
EP (2) EP0676197A3 (enExample)
JP (1) JPH05286854A (enExample)
KR (1) KR930012009A (enExample)
AT (1) ATE133334T1 (enExample)
AU (2) AU657009B2 (enExample)
CA (1) CA2084273A1 (enExample)
DE (1) DE69207885T2 (enExample)
DK (1) DK0551729T3 (enExample)
ES (1) ES2082390T3 (enExample)
GB (1) GB9125602D0 (enExample)
GR (1) GR3019270T3 (enExample)
HK (1) HK131096A (enExample)
NO (1) NO303047B1 (enExample)
NZ (1) NZ245343A (enExample)
TW (1) TW223589B (enExample)
ZA (1) ZA929316B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
GB0016045D0 (en) 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd ＩｇＥ産生抑制剤
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
MXPA06013990A (es) * 2004-04-30 2007-08-14 Virtus Nutrition Llc Sintesis de sal de metal monovalente y divalente de acido graso polinsaturado.
JP5345402B2 (ja) * 2007-01-17 2013-11-20 持田製薬株式会社 血栓もしくは塞栓に関連する疾患の予防又は治療用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1240513A (en) * 1968-09-13 1971-07-28 Ono Pharmaceutical Co Poly-unsaturated fatty acid ester composition and its preparation
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB8916734D0 (en) * 1989-07-21 1989-09-06 Efamol Holdings Pharmaceutical and dietary uses of fatty acids

Also Published As

Publication number Publication date
NZ245343A (en) 1997-06-24
NO924637L (no) 1993-06-03
EP0676197A2 (en) 1995-10-11
US5859055A (en) 1999-01-12
KR930012009A (ko) 1993-07-20
ZA929316B (en) 1993-09-09
AU657009B2 (en) 1995-02-23
JPH05286854A (ja) 1993-11-02
DE69207885T2 (de) 1996-07-25
GR3019270T3 (en) 1996-06-30
DE69207885D1 (de) 1996-03-07
NO924637D0 (no) 1992-12-01
AU2968792A (en) 1993-06-03
GB9125602D0 (en) 1992-01-29
US5378732A (en) 1995-01-03
EP0551729B1 (en) 1996-01-24
ATE133334T1 (de) 1996-02-15
DK0551729T3 (da) 1996-02-12
CA2084273A1 (en) 1993-06-03
EP0551729A1 (en) 1993-07-21
AU1656395A (en) 1995-06-29
AU680725B2 (en) 1997-08-07
NO303047B1 (no) 1998-05-25
EP0676197A3 (en) 1996-09-11
TW223589B (enExample) 1994-05-11
HK131096A (en) 1996-07-26

Similar Documents

Publication Publication Date Title
ES2052645T3 (es) Acidos poliinsaturados con accion vasocinetica y formulaciones farmaceuticas y cosmeticas que los contienen.
ES2032382T3 (es) Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis.
ES2117390T3 (es) Sales de un acido graso poliinsaturado y formulaciones farmaceuticas que las contienen.
IT1176916B (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
ES2090244T3 (es) Procedimiento para prevenir, estabilizar u ocasionar la regresion de la aterosclerosis usando una combinacion de un medicamento para disminuir el colesterol y un inhibidor de la ace.
ES2149253T3 (es) Medicamentos a base de acido docosahexaenoico como antiagregantes plaquetarios y contra las carencias cerebrales en acidos grasos esenciales y procedimientos de preparacion.
DK644388A (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
ATE22533T1 (de) Pharmazeutische zusammensetzung.
ES2082390T3 (es) Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias.
ES2045120T4 (es) Metodo para preparar un medicamento para el tratamiento o la prevencion de la perdida de memoria.
ES2052761T3 (es) Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene.
ATE98490T1 (de) Arzneimittel, das einen pharmazeutisch geeigneten traeger sowie die verbindung der struktur (7- alpha, 17-alpha)-17-hydroxy-7-methyl-19-nor-17pregn-5(10)-ene-20-yne-3-one enthaelt.
FI880387A0 (fi) 1-(4-hydroxi-3,5-di-tert -butylbenzoyl) homopiperazin, dess olika derivat, foerfarande foer framstaellning av dessa foereningar, dessa innehaollande laekemdel och deras anvaendning.
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
HUT51148A (en) Process for producing pharmaceutical compositions comprising ace-inhibitors
DK0409559T3 (da) Farmaceutisk og diætetisk anvendelse af fedtsyrer
AR009446A1 (es) Utilizacion del acido 2-(3,4-dimetoxinamoil)aminobenzoico (tranilast) en la fabricacion de un medicamento para el tratamiento o prevencion de larestenosis, composicion farmaceutica y procedimiento de preparacion.
FR2336926A1 (fr) Acide ditertiobutyl-3,5 dihydroxy-2,6 benzoique, ses sels et ses esters d'alkyle inferieur, utiles notamment pour le traitement des maladies vasculaires
DK417889A (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
FR2258173A1 (en) Acetylsalicylic acid 2-p-chlorophenoxy isobutyric acid compsns - with anticoagulant and hypocholesterolaemic effects
ATE127017T1 (de) Castanosperminester zur behandlung der zerebralen malaria.
IT8821430A0 (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 551729

Country of ref document: ES